100 Participants Needed

Web-Based End-of-Life Planning Tool for Cancer

Megan J. Shen, PhD - Associate ...
Overseen ByMegan J Shen, PhD.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Fred Hutchinson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This clinical trial examines a web-based tool, in partnership with Peacefully, Inc, designed to improve end-of-life planning among patients with advanced cancers. This program helps users prepare comprehensively for end-of-life (e.g., medical wishes, legal estate planning, financial planning and transfer of accounts, legacy building, and emotional support). It is expected that this web-based end-of-life planning program may reduce distress and improve end-of-life preparation among advanced cancer patients.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Web-Based Tool for End-of-Life Planning, Peacefully, Web-Based End-of-Life Planning Tool?

Research suggests that web-based tools for advance care planning can improve communication among patients, families, and healthcare providers, and help in identifying and addressing patient needs more effectively. These tools have been explored in various conditions, such as ovarian cancer and lung disease, indicating their potential to support end-of-life planning.12345

Is the Web-Based End-of-Life Planning Tool safe for use in humans?

The available research does not provide specific safety data for the Web-Based End-of-Life Planning Tool, but similar tools have been generally accepted and found easy to use by patients and caregivers in various studies.16789

How is the Web-Based End-of-Life Planning Tool for Cancer different from other treatments?

The Web-Based End-of-Life Planning Tool, also known as Peacefully, is unique because it is an online resource designed to help cancer patients and healthcare providers discuss and plan for end-of-life care, focusing on quality of life and advance care planning. Unlike traditional treatments that focus on medical interventions, this tool facilitates communication and decision-making about end-of-life preferences.1781011

Research Team

Megan J. Shen, PhD - Associate ...

Megan J Shen, PhD.

Principal Investigator

Fred Hutch/University of Washington Cancer Consortium

Eligibility Criteria

This trial is for adults with advanced cancer, who have a life expectancy of less than 12 months and have undergone at least one round of chemotherapy. Participants must be able to use a computer or mobile device, give informed consent, and speak English fluently. Those severely cognitively impaired or too ill to complete interviews are excluded.

Inclusion Criteria

The ability to provide informed consent
My cancer is advanced or has spread, and it got worse after my first chemotherapy.
Clinician estimated prognosis of =< 12 months
See 1 more

Exclusion Criteria

Too ill or weak to complete the interviews (as judged by the interviewer)
I am not fluent in English.
Severely cognitively impaired (as measured by Short Portable Mental Status Questionnaire scores of < 6)

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Patients receive Peacefully's web-based tool to help with end-of-life planning on day 7

4 weeks
Baseline and 4 weeks post-randomization

Control

Patients receive standard care

4 weeks
Baseline and 4 weeks post-randomization

Follow-up

Participants are monitored for changes in well-being and end-of-life planning engagement

24 weeks
Follow-up at 4, 12, and 24 weeks post-randomization

Treatment Details

Interventions

  • Web-Based Tool for End-of-Life Planning
Trial OverviewThe study tests a web-based tool created with Peacefully, Inc., aimed at helping patients with advanced cancers plan for end-of-life. It covers medical wishes, legal estate planning, financial matters, legacy building, and emotional support to potentially ease distress and improve preparation.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (Peacefully's)Experimental Treatment2 Interventions
Patients receive Peacefully's web-based tool to help with end-of-life planning on day 7.
Group II: Group II (standard of care)Active Control2 Interventions
Patients receive standard care.

Web-Based Tool for End-of-Life Planning is already approved in United States for the following indications:

🇺🇸
Approved in United States as Peacefully for:
  • End-of-life planning for patients with advanced cancers

Find a Clinic Near You

Who Is Running the Clinical Trial?

Fred Hutchinson Cancer Center

Lead Sponsor

Trials
583
Recruited
1,341,000+

Peacefully, Inc.

Collaborator

Trials
1
Recruited
100+

National Institute of Nursing Research (NINR)

Collaborator

Trials
623
Recruited
10,400,000+

Findings from Research

A web-based tool was developed to assist women with ovarian cancer in advance care planning, focusing on advance healthcare directives and palliative care, and was tested in a pilot study with 53 participants.
While the tool did not significantly increase the completion rates of advance healthcare directives or palliative care consultations, it did help reduce decisional conflict and improve user satisfaction with the information provided.
Development and pilot of an advance care planning website for women with ovarian cancer: a randomized controlled trial.Vogel, RI., Petzel, SV., Cragg, J., et al.[2021]
A Web-based advance care planning tool for lung disease received high acceptability and potential usefulness ratings from 50 stakeholders, including patients, surrogates, and clinicians, indicating strong support for its development.
Stakeholders suggested that the tool should include videos, interactive content, and allow users to control their progress, while also addressing challenges like emotional difficulties and varying levels of computer literacy.
Key stakeholders' perspectives on a Web-based advance care planning tool for advanced lung disease.Chiarchiaro, J., Ernecoff, NC., Buddadhumaruk, P., et al.[2018]
Digital technologies, like Electronic Palliative Care Coordination Systems (EPaCCS), are being explored to enhance advance care planning and coordination in palliative care, but the evidence supporting their effectiveness is still limited.
Research is essential to evaluate whether technology-mediated approaches, such as EPaCCS, can effectively improve care delivery for patients with chronic and progressive illnesses.
Building on sand: digital technologies for care coordination and advance care planning.Allsop, MJ., Chumbley, K., Birtwistle, J., et al.[2022]

References

Development and pilot of an advance care planning website for women with ovarian cancer: a randomized controlled trial. [2021]
Key stakeholders' perspectives on a Web-based advance care planning tool for advanced lung disease. [2018]
Building on sand: digital technologies for care coordination and advance care planning. [2022]
Tell Us™: a Web-based tool for improving communication among patients, families, and providers in hospice and palliative care through systematic data specification, collection, and use. [2022]
What is the potential for the use of clinical outcome measures to be computerised? Findings from a qualitative research study. [2019]
Fostering Palliative Care Through Digital Intervention: A Platform for Adult Patients With Hematologic Malignancies. [2022]
Publicly Available, Interactive Web-Based Tools to Support Advance Care Planning: Systematic Review. [2022]
Evaluation of an advance care planning web-based resource: applicability for cancer treatment patients. [2022]
Development and preliminary usability testing of an electronic conversation guide incorporating patient values and prognostic information in preparation for older people's decision-making near the end of life. [2023]
Online tool targets better skills in end of life care. [2019]
11.United Statespubmed.ncbi.nlm.nih.gov
Interactive collaborative consultation model in end-of-life care. [2019]